Novavax, Inc. (NVAX)
10.21
-0.13
(-1.26%)
USD |
NASDAQ |
Sep 04, 16:00
10.19
-0.02
(-0.20%)
After-Hours: 20:00
Novavax Net Income (Annual) : 440.30M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 440.30M |
| December 31, 2024 | -187.50M |
| December 31, 2023 | -545.06M |
| December 31, 2022 | -657.94M |
| December 31, 2021 | -1.744B |
| December 31, 2020 | -418.26M |
| December 31, 2019 | -132.69M |
| December 31, 2018 | -184.75M |
| December 31, 2017 | -183.77M |
| December 31, 2016 | -279.97M |
| December 31, 2015 | -156.94M |
| December 31, 2014 | -82.95M |
| December 31, 2013 | -51.98M |
| December 31, 2012 | -28.51M |
| December 31, 2011 | -19.36M |
| December 31, 2010 | -35.71M |
| Date | Value |
|---|---|
| December 31, 2009 | -38.37M |
| December 31, 2008 | -36.32M |
| December 31, 2007 | -28.59M |
| December 31, 2006 | -23.07M |
| December 31, 2005 | -11.17M |
| December 31, 2004 | -25.92M |
| December 31, 2003 | -17.27M |
| December 31, 2002 | -22.70M |
| December 31, 2001 | -9.745M |
| December 31, 2000 | -12.19M |
| December 31, 1999 | -4.506M |
| December 31, 1998 | -4.817M |
| December 31, 1997 | -4.547M |
| December 31, 1996 | -5.495M |
| December 31, 1995 | -8.494M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Moderna, Inc. | -2.822B |
| Merck & Co., Inc. | 18.26B |
| Pfizer Inc. | 7.787B |
| Recursion Pharmaceuticals, Inc. | -644.76M |
| Agenus, Inc. | -3.083M |